Penny Stocks Archives - Page 1144 of 1231

1 minute read

Where To Buy Martha Stewart’s New CBD Gummies? New Flavor Hits Shelves Under Partnership With Canopy Growth

August 15, 10:57 AM

Martha Stewart CBD has unveiled the latest flavor in its CBD portfolio – Pumpkin Spice CBD Wellness Gummies. The new flavor is a part of Martha's continued partnership with Canadian cannabis giant Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC).

CGC

1 minute read

VerifyMe Beats Q2 Revenue Backed By PeriShip Synergies

By Anusuya Lahiri

August 15, 10:34 AM

VerifyMe, Inc (NASDAQ:VRME) reported second-quarter FY22 revenue growth of 3,527% year-on-year to $4.5 million, beating the consensus of $3 million. The…

VRME

1 minute read

AmpliTech Shares Gain On Q2 Beat, Guidance Boost

By Anusuya Lahiri

August 15, 10:16 AM

AmpliTech Group, Inc (NASDAQ:AMPG) reported second-quarter FY22 revenue growth of 347.5% year-on-year to $4.58 million, beating the consensus of $4.10 million.…

AMPG

2 minute read

EXCLUSIVE: Keep Calm And Carry CBD Softgels With THC, CV Sciences Launches Relaxation Products

By Nina Zdinjak

August 15, 10:00 AM

Hemp CBD manufacturer CV Sciences, Inc. (OTCQB: CVSI) has launched +PlusCBD Reserve Collection softgels to support stress relief and relaxation. This new CBD collection will be available online starting August 15th at $54.99 per 60-count bottle.

CVSI

1 minute read

Here’s Why Arcadia Biosciences Shares Are Falling

By Henry Khederian

August 15, 9:50 AM

Arcadia Biosciences Inc (NASDAQ: RKDA) shares are trading lower by 12.1% to $0.91 Monday morning after the company announced a registered direct offering of 4,722,506 shares at a purchase price of $1.06 per share. What Else?

RKDA

1 minute read

BrainStorm To File US Application For NurOwn In Amyotrophic Lateral Sclerosis

By Vandana Singh

August 15, 9:49 AM

BrainStorm Cell Therapeutics Inc (NASDAQ: BCLI) announced its decision to submit a marketing application to the FDA seeking approval for NurOwn for…

BCLI

1 minute read

Anixa Initiates Patient Dosing in Initial-Stage Ovarian Cancer Study

By Ragothaman Srinivasan

August 15, 9:47 AM

Anixa Biosciences (NASDAQ: ANIX) commenced treatment of the first patient in the clinical trial of its novel chimeric antigen receptor T-cell (CAR-T) therapy for ovarian cancer.

ANIX

2 minute read

Columbia Care Q2 Revenue Grows 18.1% YoY, What About Adjusted EBITDA?

By Vuk Zdinjak

August 15, 9:28 AM

Columbia Care Inc. (OTCQX: CCHWF) (NEO:CCHW) (CSE:CCHW) (FSE: 3LP) released financial results for the second quarter ended June 30, 2022, revealing revenue of $129.6 million, an 18.1% increase compared to $109.7 million in Q2 2021.

CCHWF

1 minute read

Why Unity Stock Is Falling Today

By Adam Eckert

August 15, 9:14 AM

Unity Software Inc (NYSE: U) shares are trading lower Monday after the company's board announced its commitment to the ironSource Ltd (NYSE: IS) transaction and rejected the unsolicited proposal from Applov

APP

1 minute read

Clene Shares Fall Despite Multiple Sclerosis Candidate Showing Neurological Improvements

By Vandana Singh

August 15, 9:04 AM

Clene Inc (NASDAQ:CLNN) has announced topline results from the Phase 2 VISIONARY-MS trial of CNM-Au, an investigational gold nanocrystal suspension, in…

CLNN